Phase
Condition
Infertility
Treatment
N/AClinical Study ID
Ages 18-36 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Women aged ≥ 18 and ≤ 36
Undergoing ovarian stimulation for an In Vitro Fertilization (IVF) or IntraCytoplasmic Sperm Injection (ICSI)
Having experienced no more than 1 Embryo Transfer failure
With basal FSH level ≤ 12 IU/l within the 6 months prior to the study
Endometrial biopsy during the menstrual cycle preceding the ovarian stimulation (6 to 12 days after a documented ovulation)
Negative serology for HIV 1 and 2, hepatitis B and C, HTLV 1 and 2, syphilis
Exclusion
Exclusion Criteria:
Hypersensitivity to one of the culture media components
Oocyte donation, sperm donation
Thawed embryos transfer
Women with endometriosis grade III and IV, chronic endometritis, hydrosalpinx,polycystic ovary, amenorrhoea, anovulation, uterus with malformation, uncontrolledprolactinaemia, uterine synechia, uterine fibroma, women exposed to distilbene,uterine polyps
Women affected by pathologies associated with any contraindication of being pregnant
Abnormal gynaecologic bleeding of undetermined origin
Uncontrolled thyroid (TSH dosage) or adrenal dysfunction
Neoplasias, any pathologies of the endometrium or the cervix
Study Design
Connect with a study center
CMCO
Schiltigheim, 67303
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.